The Latest Breaking News from Turning Point

Turning Point Brand Names New CEO Turning Point Brands, Inc. (NYSE: TPB) has tapped a long-tenured company executive Graham Purdy as CEO and board director following Yavor Efremov's resignation, less than a year following his appointment.

The U.S. market came back in July and early August owing to a robust job market, strong corporate earnings, and a slight decline in inflation. However, the Fed’s hawkish stance to hike the interest rates aggressively until inflation comes down to the target level is expected to keep the market…

IDEAYA Biosciences (NASDAQ:IDYA) has entered into a clinical trial collaboration and supply agreement with Amgen Inc. to evaluate the efficacy and safety of IDE397 with Amgen's AMG 193  in a Phase 1 clinical trial. IDEAYA shares traded in a range of $14.59 to $15.82 on a day volume of 130.58…

TAMPA, Fla. — Calling it “an indefensible act of hatred,” the Florida Holocaust Museum sharply condemned demonstrations at the Tampa Convention Center where a group of neo-fascists waved flags with swastikas outside Turning Point USA’s Student Action Summit.

ATLANTA — A special committee will investigate the hiring of a law clerk by the chief judge of the federal appeals court in Atlanta in light of allegations the clerk had sent racist and xenophobic texts, a judicial panel ruled Friday.

How crime and drugs destroyed dad's life after movie debut

Turning Point Brands Inc (NYSE:TPB) has partnered with marketing and sales agency Petalfast Inc. for the distribution expansion of its rolling paper brand, Zig-Zag. Turning Point acquired the license to distribute Zig-Zag in North America in 1997. Under the agreement, Petalfast will provide full-service sales and marketing support to Zig-Zag and…

Petalfast Inc., a full-spectrum marketing and sales agency for the cannabis industry, entered into partnership with Turning Point Brands, Inc. (NYSE: TPB), to drive distribution expansion of their iconic rolling paper brand, Zig-Zag

Destigmatising addiction and acknowledging its relationship with trauma would help sufferers get help sooner, says an expert and a recovering heavy drug user.

Bristol Myers Squibb is the IBD Stock Of The Day as BMY stock bounds off its 50-day line, presenting investors with an early entry.

Upgrades